The results of the current study suggest that vitamin D supplementation, taken even at a dose of 2000 IU/d by nondiabetic and vitamin D–replete adolescents with obesity for 12 weeks, has no effect on insulin sensitivity and pancreatic b-cell function, or on lipid profile [186]. The gene discussed is INS; the disease is obesity disorder.